Aspergillopepsin is a protein-digesting enzyme produced by Aspergillus fungi, a group of common molds found in soil and decaying organic matter. It belongs to a family of enzymes called aspartic endopeptidases, meaning it breaks apart proteins by cutting the internal bonds that hold amino acids together. The enzyme has gained attention primarily for its ability to break down gluten in the stomach, making it a key ingredient in several digestive enzyme supplements.
How Aspergillopepsin Works
Proteins are long chains of amino acids linked by peptide bonds. Aspergillopepsin acts like molecular scissors, cutting those chains at multiple points with broad specificity. Unlike some enzymes that only snip at one or two types of bonds, aspergillopepsin chops proteins into smaller and smaller fragments. This is useful because shorter protein fragments are easier for your body’s own digestive enzymes to finish breaking down into individual amino acids.
The enzyme is classified under EC 3.4.23.18, placing it in the same broad category as pepsin, the acid-activated protease your stomach naturally produces. Several Aspergillus species make it, including A. niger, A. oryzae, A. fumigatus, and A. sojae. The version most studied for digestive supplements comes from Aspergillus niger and is often abbreviated AN-PEP (Aspergillus niger prolyl endoprotease).
Why It Matters for Gluten Digestion
Gluten contains unusually long, tightly packed chains of amino acids that human digestive enzymes struggle to fully break apart. One notorious fragment, known as the 33-mer peptide, survives stomach acid and pancreatic enzymes largely intact. In people with celiac disease or gluten sensitivity, these surviving fragments trigger immune reactions in the small intestine.
Aspergillopepsin is stable at a pH of around 2, which is roughly how acidic your stomach gets during a meal. It also resists being broken down by pepsin, the protease already present in gastric juice. These two traits allow it to remain active in the stomach long enough to attack gluten fragments before they reach the small intestine, where they would otherwise cause problems.
In laboratory settings, fungal proteases like aspergillopepsin handle the initial heavy lifting, chopping gluten into intermediate-sized pieces of roughly 4 to 40 amino acids. Bacterial enzymes from sourdough lactobacilli, or your body’s own brush-border enzymes, can then reduce those pieces further into harmless individual amino acids. Without that first round of cutting, the smaller enzymes have nothing to work with.
What Clinical Trials Show
A randomized, placebo-controlled crossover study published in Scientific Reports tested AN-PEP in 18 gluten-sensitive participants. Each person ate a porridge containing 0.5 grams of gluten (roughly the amount in a small piece of bread) along with either a high dose of the enzyme, a low dose, or a placebo.
In the stomach, both doses performed similarly well. The high dose reduced gluten levels by 88%, and the low dose reduced them by 86%, compared to placebo. Both results were statistically significant. In the duodenum (the first section of the small intestine), the high dose cut gluten levels by 56% and the low dose by 48%. The primary goal of the study, defined as at least 50% gluten degradation in the duodenum compared to placebo, was met in 10 out of 13 comparisons for the high dose.
These numbers are meaningful but come with an important caveat: the study used a controlled, relatively small amount of gluten. A plate of pasta contains far more than 0.5 grams, and no enzyme supplement has been shown to fully neutralize a standard gluten-containing meal. Aspergillopepsin is being explored as a safety net for accidental, low-level gluten exposure, not as a replacement for a gluten-free diet in people with celiac disease.
How It Appears in Supplements
You’ll find aspergillopepsin listed on supplement labels under several names: AN-PEP, Aspergillus niger prolyl endoprotease, or simply “fungal protease.” It often appears alongside another enzyme called dipeptidyl peptidase IV (DPP-IV), which handles a complementary step in protein digestion. The idea behind combining them is that aspergillopepsin breaks large proteins into medium fragments, and DPP-IV trims those fragments further, particularly at proline-rich bonds that are common in gluten.
These products are marketed as digestive aids for gluten sensitivity, though some broader digestive enzyme blends include aspergillopepsin for general protein digestion as well. Dosing varies by product and is typically listed in enzyme activity units rather than milligrams, since the amount of active enzyme matters more than the weight of the powder.
Safety and Allergy Risk
The European Food Safety Authority (EFSA) has evaluated aspergillopepsin I multiple times as a food enzyme. Their assessments have consistently found it safe for use in food processing and as a dietary ingredient, with one notable consideration: a small possibility of allergic reactions.
When researchers compared the enzyme’s amino acid sequence against databases of known allergens, they found a 78.7% match with Asp f 10, a respiratory allergen produced by Aspergillus fumigatus. This is the same mold responsible for allergic bronchopulmonary aspergillosis, a condition affecting some people with asthma or compromised immune systems. EFSA concluded that the risk of allergic reactions from eating the enzyme cannot be ruled out entirely but is low. Allergic reactions to dietary exposure have been documented, though they are rare.
If you have a known allergy to Aspergillus molds, it’s worth being cautious with supplements containing this enzyme. The cross-reactivity between inhaled mold allergens and ingested fungal enzymes is not fully mapped, but the structural similarities are real.
Limitations Worth Knowing
Aspergillopepsin degrades gluten effectively in controlled conditions, but the human digestive system is not a controlled environment. Meal composition, stomach emptying speed, the amount of gluten consumed, and individual variation in gastric pH all affect how much work the enzyme can do before food moves into the small intestine. The clinical trial showing 88% stomach degradation used a simple porridge, not a complex, high-fat meal that would empty more slowly and buffer stomach acid differently.
No medical organization currently recommends enzyme supplements as a treatment for celiac disease. For people with non-celiac gluten sensitivity who follow a gluten-free diet but worry about trace contamination at restaurants or in packaged foods, aspergillopepsin supplements offer a partial buffer, not a guarantee.